https://www.selleckchem.com/pr....oducts/Everolimus(RA
4% vs. 30.1%, = 0.044). Survivors had fewer metabolic syndrome features compared with NHANES (≥2 features 26.7% vs. 55.9%; 0.001). Survivors were more physically active and smoked tobacco less (both 0.0001). Therefore, general population cardiovascular risk scores were lower for survivors versus NHANES. However, with CCSS models, 30.5% of survivors were at moderate risk of ischemic heart disease, and 95% at moderate/high risk for heart failure, with a 9% to 12% predicted incidence of these conditions by age 50 y
Like
Comment
Share
